10 Year Financial Data of Hi-Tech Pharmacal Co., Inc. (HITK)

32.27 (1y: +7%)

Market Cap	426.67 M	P/E(ttm)	14.30
Enterprise Value	340.41 M	P/B	1.85

HITK- NAS (USA)
Hi-Tech Pharmacal Co., Inc.

Currently 1/5

Business Predictability Rank: 1-Star (On Watch)
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$32.27

1 Severe Warning Sign 1 Medium Warning Sign 1 Good Sign

Bookmark

Annual Rates (per share)	10 yrs*	5 yrs*	12 months*
Revenue Growth (%)	18.3	31.5	2.3
EBITDA Growth (%)	0	0	-32.4
Free Cash Flow Growth (%)	0	0	216.4
Book Value Growth (%)	17.6	29.5	9.1

*12-month growth rate is calculated with the per share revenue (EBITDA, FCF, earnings) of the last 12 months over the per share revenue (EBITDA, FCF, earnings) over the previous 12 months. 5-year and 10-year growth rates are calculated with least-square regression based on the 5-year and 10-year numbers.

Trendline:

Export:

Print This Table Print

See this page for the explanation of the data and charts * All numbers are in millions except for per share data

Per Share Data	Annuals											Quarterly
Fiscal Period	Apr03	Apr04	Apr05	Apr06	Apr07	Apr08	Apr09	Apr10	Apr11	Apr12	TTM	Jan12	Apr12	Jul12	Oct12	Jan13

Revenue per Share ($)	4.11	4.24	5.21	5.82	4.96	5.46	9.29	13.17	14.67	17.10	17.25	4.07	4.48	3.84	4.24	4.69
EBITDA per Share	0.86	0.83	1.11	1.36	-0.22	-0.39	1.67	3.90	5.34	5.88	4.13	1.06	1.85	0.67	0.97	0.64
Free Cashflow per Share	0.35	0.25	0.32	0.25	-0.16	-1.14	0.19	0.47	1.89	1.35	1.93	-0.01	0.96	0.20	0.59	0.18
Earnings per Share ($)	0.49	0.49	0.64	0.85	-0.17	-0.45	0.84	2.50	3.19	3.59	2.26	0.79	0.73	0.44	0.66	0.43
Book Value per Share	3.03	5.03	5.36	6.60	6.98	6.62	7.39	10.85	13.91	17.57	18.10	16.59	17.29	18.12	19.02	18.10
Month End Stock Price	22.60	13.83	15.73	24.41	13.24	8.75	7.55	24.33	27.66	32.59	36.60	38.98	32.59	34.36	31.35	36.60
Ratios	Annuals											Quarterly
Fiscal Period	Apr03	Apr04	Apr05	Apr06	Apr07	Apr08	Apr09	Apr10	Apr11	Apr12	Latest Q.	Jan12	Apr12	Jul12	Oct12	Jan13

Return on Equity %	16.30	9.90	11.90	12.90	-2.50	-6.80	11.40	23.10	22.90	20.50	9.60	19.20	16.80	9.60	14.00	9.60
Return on Assets %	13.10	8.70	10.20	11.40	-2.10	-6.00	9.10	20.70	20.40	17.30	8.40	16.40	14.40	8.80	12.40	8.40
Return on Capital - Joel Greenblatt %	42.60	37.60	40.70	41.80	-14.00	-14.30	26.00	60.20	67.30	63.70	27.60	50.40	60.00	31.60	44.80	27.60
Debt to Equity	0.00	--	--	--	--	--	0.05	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.01

Gross Margin %	50.50	53.50	53.70	54.10	39.40	34.70	47.60	56.40	56.40	56.20	51.10	55.30	51.90	48.70	51.40	51.10
Operating Margin %	18.10	17.00	18.30	20.00	-9.30	-11.80	14.60	27.00	33.80	30.60	13.60	26.00	27.00	17.50	22.90	13.60
Net Margin %	12.10	11.70	12.20	14.70	-3.50	-8.20	9.00	19.00	21.70	21.00	9.20	19.40	16.30	11.50	15.50	9.20

Days Sales Outstanding	43.10	63.80	84.10	78.20	57.80	104	107	90.20	110	95.40	106	91.20	89.20	101	106	106
Days Inventory	106	98.90	103	93.00	148	162	110	104	104	142	114	147	121	140	124	114
Inventory Turnover	3.40	3.70	3.50	3.90	2.50	2.20	3.30	3.50	3.50	2.60	0.80	0.60	0.80	0.70	0.70	0.80

Debt to Revenue	0.00	--	--	--	--	--	0.04	0.00	0.00	0.01	0.02	0.03	0.03	0.03	0.03	0.02
COGS to Revenue	0.50	0.46	0.46	0.46	0.61	0.65	0.52	0.44	0.44	0.44	0.49	0.45	0.48	0.51	0.49	0.49
Inventory to Revenue	0.14	0.13	0.13	0.12	0.25	0.29	0.16	0.12	0.13	0.17	0.61	0.72	0.64	0.79	0.66	0.61
Interest Exp. to Revenue %	0.37	0.46	0.93	2.47	2.20	0.73	3.87	0.75	0.20	0.21	-0.12	0.34	0.05	-0.21	-0.12	-0.12

Asset Turnover	1.08	0.75	0.83	0.78	0.60	0.73	1.01	1.09	0.94	0.82	0.22	0.21	0.22	0.19	0.20	0.22
Buyback Ratio	-21.70	-364	-6.80	-26.30	--	8.40	--	--	--	-6.20	--	--	-0.30	--	--	--
Income Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Apr03	Apr04	Apr05	Apr06	Apr07	Apr08	Apr09	Apr10	Apr11	Apr12	TTM	Jan12	Apr12	Jul12	Oct12	Jan13

Revenue	47.45	56.37	67.68	78.02	58.90	62.02	109	164	191	230	235	55.63	61.29	52.04	57.54	64.33
Cost of Goods Sold	23.51	26.21	31.36	35.83	35.70	40.51	56.97	71.33	83.26	101	116	24.89	29.46	26.72	27.95	31.45
Gross Profit	23.94	30.16	36.32	42.19	23.19	21.51	51.68	92.36	108	129	120	30.74	31.83	25.32	29.59	32.88

Selling, General, &Admin. Expense	13.26	16.76	19.57	23.21	23.91	22.63	33.29	45.14	39.10	44.70	48.88	13.26	10.01	10.63	11.71	16.54
Research &Development	2.10	3.82	4.37	3.33	4.73	6.21	7.43	7.56	9.35	12.26	17.15	3.02	3.37	4.47	3.34	5.96
Earnings Before DDA	9.91	11.06	14.43	18.26	-2.62	-4.40	19.48	48.42	69.51	79.06	56.30	14.46	25.27	9.10	13.18	8.76

Depreciation, Depletion and Amortization	1.33	1.48	2.05	2.62	2.84	2.92	3.63	4.29	5.10	8.73	8.73	--	8.73	--	--	--

Operating Income	8.58	9.58	12.38	15.64	-5.45	-7.32	15.85	44.13	64.41	70.33	47.57	14.46	16.54	9.10	13.18	8.76
Interest Income/Expense	0.17	0.26	0.63	1.93	1.30	0.45	4.21	1.23	0.39	0.48	-0.23	0.19	0.03	-0.11	-0.07	-0.08
Net Income	5.73	6.59	8.29	11.45	-2.04	-5.10	9.82	31.12	41.45	48.35	30.86	10.81	9.99	6.00	8.92	5.94

Earnings per Share ($)	0.49	0.49	0.64	0.85	-0.17	-0.45	0.84	2.50	3.19	3.59	2.26	0.79	0.73	0.44	0.66	0.43
Total Shares Outstanding	11.56	13.29	12.99	13.40	11.88	11.35	11.69	12.43	13.01	13.45	13.73	13.68	13.67	13.55	13.58	13.73
Balance Sheet	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Apr03	Apr04	Apr05	Apr06	Apr07	Apr08	Apr09	Apr10	Apr11	Apr12	Latest Q.	Jan12	Apr12	Jul12	Oct12	Jan13

Cash and cash equivalents	15.58	42.63	37.13	43.51	33.27	11.72	17.89	36.02	62.30	87.55	87.60	74.34	87.55	92.25	104	87.60
Accounts Receivable	5.61	9.85	15.60	16.72	9.33	17.60	31.90	40.45	57.63	60.11	74.74	55.73	60.11	57.79	67.16	74.74
Inventory	6.82	7.10	8.85	9.13	14.49	18.02	17.18	20.36	23.78	39.28	39.43	40.15	39.28	41.09	38.03	39.43
Other Current Assets	3.55	3.39	3.23	5.84	9.96	7.74	8.12	7.35	10.02	14.89	13.21	15.93	14.89	12.02	9.20	13.21
Total Current Assets	31.56	62.98	64.81	75.21	67.04	55.09	75.09	104	154	202	215	186	202	203	218	215

Property, Plant and Equipment	11.57	12.32	13.54	15.74	16.60	17.05	19.21	20.43	25.87	29.98	31.23	29.19	29.98	30.26	30.51	31.23
Intangible Assets	--	--	2.94	7.83	6.09	9.66	12.47	24.32	21.23	46.06	42.17	45.49	46.06	44.40	42.64	42.17
Other Long Term Assets	0.69	0.25	0.33	1.61	8.01	3.21	0.59	1.36	2.40	1.25	0.29	2.15	1.25	1.10	0.96	0.29
Total Assets	43.83	75.55	81.61	100	97.74	85.01	107	150	203	279	289	263	279	279	293	289

Accounts Payable	7.42	7.21	10.59	9.97	11.50	9.22	15.34	15.29	21.46	31.04	29.00	23.59	31.04	22.41	23.86	29.00
Current Portion of Long-Term Debt	0.06	--	--	--	--	--	4.32	0.19	0.04	0.36	0.36	0.36	0.36	0.36	0.36	0.36
Other Current Liabilities	-0.00	--	0.19	--	--	--	-0.00	--	0.11	2.88	2.88	2.88	2.88	2.88	2.88	2.88
Total Current Liabilities	7.48	7.21	10.78	9.97	11.50	9.22	19.65	15.48	21.61	34.27	32.23	26.82	34.27	25.64	27.09	32.23

Long-Term Debt	--	--	--	--	--	--	0.23	0.04	0.62	1.24	0.98	1.33	1.24	1.15	1.07	0.98
Other Long-Term Liabilities	1.31	1.56	1.16	1.97	3.25	0.63	1.12	--	0.00	7.23	6.94	7.80	7.23	6.64	6.05	6.94
Total Liabilities	8.79	8.76	11.95	11.94	14.76	9.85	21.00	15.52	22.23	42.74	40.15	35.96	42.74	33.44	34.21	40.15

Common Stock	0.07	0.08	0.09	0.13	0.13	0.14	0.14	0.15	0.15	0.16	0.16	0.16	0.16	0.16	0.16	0.16
Retained Earnings	22.29	28.88	37.17	48.62	46.59	41.49	51.30	82.43	124	172	173	162	172	178	187	173
Additional Paid-In Capital	13.48	38.82	40.36	47.20	50.78	54.83	57.98	75.35	79.98	87.00	99.73	87.63	87.00	90.07	94.07	99.73
Treasury Stock	-0.80	-1.00	-7.95	-7.95	-19.39	-21.35	-23.00	-23.00	-23.00	-23.00	-24.30	-23.00	-23.00	-23.00	-23.00	-24.30
Total Equity	35.04	66.79	69.67	88.44	82.99	75.17	86.36	135	181	236	249	227	236	245	258	249
Cashflow Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Apr03	Apr04	Apr05	Apr06	Apr07	Apr08	Apr09	Apr10	Apr11	Apr12	TTM	Jan12	Apr12	Jul12	Oct12	Jan13

Net Income	5.73	6.59	8.29	11.45	-2.04	-5.10	9.82	31.12	41.45	48.35	48.35	--	48.35	--	--	--
Depreciation, Depletion and Amortization	1.33	1.48	2.05	2.62	2.84	2.92	3.63	4.29	5.10	8.73	8.73	--	8.73	--	--	--
Cash Flow from Discontinued Operations	--	--	--	--	--	--	--	--	0.21	--	--	--	--	--	--	--
Cash Flow from Others	0.36	-2.49	-3.25	-0.99	0.35	-7.27	-6.52	-14.28	-13.68	-11.31	-20.02	3.05	-38.69	4.04	10.44	4.20
Cash Flow from Operations	7.42	5.57	7.09	13.08	1.15	-9.45	6.93	21.13	33.09	45.77	37.06	3.05	18.39	4.04	10.44	4.20

Investment for Property, Plant & Equipement	-3.41	-2.23	-2.98	-9.70	-3.00	-3.52	-4.66	-15.30	-8.48	-27.55	-10.83	-3.14	-5.29	-1.31	-2.46	-1.78
Cash Flow from Acquisitions	--	--	--	--	--	-5.96	-1.22	-6.20	-1.44	-0.50	--	--	--	--	--	--
Cash Flow from Investing	-3.41	-12.23	-6.21	-24.70	0.22	13.04	0.41	-19.15	-9.77	-26.36	-12.17	-3.86	-4.57	-1.31	-2.46	-3.83

Net Issuance of Stock	1.25	23.76	-6.38	3.01	-11.44	-1.53	-1.65	--	--	2.98	6.80	1.69	0.17	2.02	2.39	2.22
Net Issuance of Debt	-0.16	-0.06	--	--	0.25	--	-0.14	-0.18	0.43	0.94	-0.36	-0.09	-0.09	-0.67	0.50	-0.09
Cash Flow for Dividends	--	--	--	--	--	--	--	--	--	--	-20.18	--	--	--	--	-20.18
Other Financing	--	--	--	--	0.51	0.47	0.62	16.33	2.33	1.92	2.09	1.97	-0.70	0.63	0.98	1.19
Cash Flow from Financing	1.09	23.70	-6.38	3.01	-10.69	-1.06	-1.17	16.15	2.75	5.84	-11.64	3.58	-0.62	1.97	3.87	-16.86

Net Change in Cash	5.10	17.04	-5.50	-8.62	-9.31	2.52	6.17	18.13	26.29	25.25	13.25	2.77	13.21	4.70	11.84	-16.50

Free Cash Flow	4.01	3.35	4.11	3.38	-1.85	-12.97	2.27	5.84	24.61	18.22	26.23	-0.09	13.11	2.73	7.98	2.42
Valuation Ratios (Daily)	Annuals											Quarterly
Fiscal Period	Apr03	Apr04	Apr05	Apr06	Apr07	Apr08	Apr09	Apr10	Apr11	Apr12	Latest Q.	Jan12	Apr12	Jul12	Oct12	Jan13

PE Ratio(ttm)
Price to Tangible Book
Price-to-Free-Cash-Flow ratio
PS Ratio
EV-to-Revenue
EV-to-EBITDA
EV-to-EBIT
Earnings Yield (Joel Greenblatt)
Forward Rate of Return
Shiller PE Ratio
Valuation and Quality	Annuals											Quarterly
Fiscal Period	Apr03	Apr04	Apr05	Apr06	Apr07	Apr08	Apr09	Apr10	Apr11	Apr12	Latest Q.	Jan12	Apr12	Jul12	Oct12	Jan13

Market Cap
Enterprise Value
Month End Stock Price
Net Cash (per share)
Net Current Asset Value (per share)
DCF (per share)
Median PS (per share)
Peter Lynch Fair Value (per share)
Graham Number (per share)
Altman Z-Score
Piotroski F-Score
Beneish M-Score

Switch to Another Stock:

HITK Quarterly/Annuals Reports

HITK: 10-Q - HI TECH PHARMACAL CO INC (0000887497) (Filer): (10-Q) - 2012-12-07
HITK: 10-Q - HI TECH PHARMACAL CO INC (0000887497) (Filer): (10-Q) - 2012-09-10
HITK: 10-K - HI TECH PHARMACAL CO INC (0000887497) (Filer): (10-K) - 2012-07-13
HITK: 10-Q - HI TECH PHARMACAL CO INC (0000887497) (Filer): (10-Q) - 2012-03-09
HITK: 10-Q - HI TECH PHARMACAL CO INC (0000887497) (Filer): (10-Q) - 2011-12-08

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles

HITK Quarterly/Annuals Reports